Accessibility Menu
 
VitaSpring Biomedical logo

VitaSpring Biomedical

(OTC) VSBC

Current Price$0.01
Market Cap$2.30M
Since IPO (2019)-97%
5 Year-100%
1 Year-93%
1 Month-99%

VitaSpring Biomedical Financials at a Glance

Market Cap

$2.30M

Revenue (TTM)

$4.98M

Net Income (TTM)

$935.89K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

4.68 (High)

Price

$0.01

Volume

408

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $1.00

VSBC News

No articles available.

VSBC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About VitaSpring Biomedical

Industry

Biotechnology

Employees

1

CEO

Cheng Hsiang Kao

Headquarters

Irvine, CA 92618, US

VSBC Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

2%

Return on Assets

-5%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.30M

Shares Outstanding

207.03M

Volume

408

Short Interest

0.00%

Avg. Volume

161.82

Financials (TTM)

Gross Profit

$219.34K

Operating Income

$4.18M

EBITDA

$3.95M

Operating Cash Flow

$77.56K

Capital Expenditure

$4.00

Free Cash Flow

$77.56K

Cash & ST Invst.

$29.66K

Total Debt

$262.98K

VitaSpring Biomedical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2023YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$3.77K

-122.6%

Gross Margin

0.00%

N/A

Market Cap

$2.30M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$138.00K

-0.4%

EBITDA

$179.18K

-34.0%

Quarterly Fundamentals

Name
Q3 2023YOY CHG

Net Cash

$305.58K

-4.1%

Accounts Receivable

$2.02M

N/A

Inventory

$0.00

N/A

Long Term Debt

$567.46K

-13.9%

Short Term Debt

$91.81K

-74.2%

Return on Assets

-5.44%

N/A

Return on Invested Capital

1.81%

N/A

Free Cash Flow

$2.46K

+100.6%

Operating Cash Flow

$2.46K

+100.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GGBXFGreen Growth Brands Inc.
$0.00+0.00%
POLBFPoolbeg Pharma PLC
$0.06-14.45%
IUGNFImugene Limited
$0.15+7.14%
AURXNuo Therapeutics, Inc.
$1.25-10.07%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
QQQInvesco QQQ Trust
$582.06-0.02%
CSCOCisco Systems
$77.65-0.01%

Questions About VSBC

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.